New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果